Format

Send to

Choose Destination
See comment in PubMed Commons below
Pediatr Clin North Am. 2000 Aug;47(4):867-76.

Topical therapies and medications in the pediatric patient.

Author information

1
Department of Dermatology, University of Texas Medical School at Houston, USA. dmetry@utmmg.med.uth.tmc.edu

Abstract

Topical medications and therapies are necessary for the proper management of skin diseases in children; however, physicians must be aware of the differences in percutaneous absorption and the risks for toxicity from topical medications, which are often unique to infants and children. Topical therapy must be individualized, and success often depends on proper vehicle selection, ease of application, and cost to patients and their families. Although many commercially available topical therapies are not FDA approved for use in children, recently enacted legislation has served to stimulate much-needed drug research in pediatric patients. New therapies on the horizon, such as tacrolimus, may prove to be equally efficacious and less toxic.

PMID:
10943262
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center